Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Exploring concurrent validity of the CLN2 Clinical Rating Scale: Comparison to PedsQL using cerliponase alfa clinical trial dataPloS one, 2024-05, Vol.19 (5), p.e0302382-e0302382 [Peer Reviewed Journal]Copyright: © 2024 Specchio et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ;COPYRIGHT 2024 Public Library of Science ;2024 Specchio et al 2024 Specchio et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0302382 ;PMID: 38776275Full text available |
|
2 |
Material Type: Newsletter Article
|
ALX Oncology Holdings (ALXO: $14.21) accelerates decline; Chief Medical Officer Randolph Sophia sells; -81c [5.4%]News Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd May 18, 2024Digital Resources/Online E-Resources |
|
3 |
Material Type: Newsletter Article
|
Shattuck Labs (STTK: $7.84) in 5th consecutive fall; -$2.82 [26.5%] Vol Index 1.3 [1 is avg]News Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd May 17, 2024Digital Resources/Online E-Resources |
|
4 |
Material Type: Newsletter Article
|
ALX Oncology Holdings (ALXO: $14.66) in 5th consecutive fall; Chief Medical Officer Randolph Sophia sells; -$2.29 [13.5%]News Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd May 17, 2024Digital Resources/Online E-Resources |
|
5 |
Material Type: Newsletter Article
|
ALX Oncology Holdings (ALXO: $15.02) in 4th consecutive fall; -$1.93 [11.4%]News Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd May 16, 2024Digital Resources/Online E-Resources |
|
6 |
Material Type: Newsletter Article
|
Kineta (KA: 43.0c) drops to one-month low; -9c [17.3%]News Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd May 16, 2024Digital Resources/Online E-Resources |
|
7 |
Material Type: Newsletter Article
|
ALX Oncology Holdings (ALXO: $15.19) drops to 21-day low; -42c [2.7%]News Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd May 15, 2024Digital Resources/Online E-Resources |
|
8 |
Material Type: Newsletter Article
|
ALX Oncology Holdings top gainer in The Financial Advisory Group soars 45.4% in 46 days; -60c [3.7%]News Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd May 14, 2024Digital Resources/Online E-Resources |
|
9 |
Material Type: Newsletter Article
|
ALX Oncology Holdings top gainer in Bourgeon Capital Management soars 52.0% in 42 days; -74c [4.4%]News Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd May 11, 2024Digital Resources/Online E-Resources |
|
10 |
Material Type: Newsletter Article
|
ALX Oncology Holdings (ALXO: $16.95) climbs 2.0% strengthening above moving average price; CEO Jaume Pons sells; +34c [2.0%]News Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd May 10, 2024Digital Resources/Online E-Resources |
|
11 |
Material Type: Newsletter Article
|
ALX Oncology Holdings (ALXO: $16.61) tumbles 5.4%; -95c [5.4%]News Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd May 9, 2024Digital Resources/Online E-Resources |
|
12 |
Material Type: Newsletter Article
|
Cogent Biosciences (COGT: $7.78) climbs 2.8% on rising relative strength, hits 70-day high; +21c [2.8%]News Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd May 8, 2024Digital Resources/Online E-Resources |
|
13 |
Material Type: Newsletter Article
|
ALX Oncology Holdings top gainer in Bourgeon Capital Management soars 41.5% in 39 days, hits twenty-five-month high; +$1.78 [11.3%] Vol Index 1.6 [1 is avg]News Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd May 8, 2024Digital Resources/Online E-Resources |
|
14 |
Material Type: Newsletter Article
|
Nuvectis Pharma (NVCT: $7.56) plunges 7.1% weakening below moving average price; -58c [7.1%] Vol Index 2.6 [1 is avg]News Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd May 7, 2024Digital Resources/Online E-Resources |
|
15 |
Material Type: Newsletter Article
|
BioAtla (BCAB: $3.13) slides 3.7% on slipping relative strength; -12c [3.7%]News Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd May 7, 2024Digital Resources/Online E-Resources |
|
16 |
Material Type: Newsletter Article
|
Two-bagger ALX Oncology Holdings (ALXO: $15.98) gains 4.0% on firm volume; +62c [4.0%]News Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd May 7, 2024Digital Resources/Online E-Resources |
|
17 |
Material Type: Newsletter Article
|
ALX Oncology Holdings (ALXO: $15.50) accelerates decline, down 8.5% in 2 days; -$1.44 [8.5%]News Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd May 4, 2024Digital Resources/Online E-Resources |
|
18 |
Material Type: Newsletter Article
|
Greenwich LifeSciences (GLSI: $14.19) drops 1.8% on slipping relative strength; -26c [1.8%]News Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd May 18, 2024Digital Resources/Online E-Resources |
|
19 |
Material Type: Newsletter Article
|
Anixa Biosciences (ANIX: $2.85) drops to six-month low; -6c [2.1%]News Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd May 18, 2024Digital Resources/Online E-Resources |
|
20 |
Material Type: Newsletter Article
|
Kineta (KA: 45.0c) closes at 19% below VWAP; reports Loss of $10.2m; -3c [6.2%]News Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd May 18, 2024Digital Resources/Online E-Resources |